Detalhe da pesquisa
1.
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.
Blood
; 142(1): 44-61, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023372
2.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
3.
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Eur J Haematol
; 108(5): 369-378, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030282
4.
Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients.
Int J Mol Sci
; 22(17)2021 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502260
5.
Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.
Bioinformatics
; 35(17): 2924-2931, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689715
6.
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.
Lancet Oncol
; 20(11): 1576-1586, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582354
7.
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
Br J Haematol
; 183(5): 727-735, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30460980
8.
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood
; 137(16): 2267-2271, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512465
9.
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways.
Haematologica
; 103(12): 2069-2078, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976738
10.
Semi-automated cancer genome analysis using high-performance computing.
Hum Mutat
; 38(10): 1325-1335, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598576
11.
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
Eur J Haematol
; 98(3): 254-262, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862308
12.
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Mol Cancer
; 14: 114, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041471
13.
Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.
Bioinformatics
; 35(17): 3216, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161200
14.
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.).
Haematologica
; 104(11): e540, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666345
15.
Machine learning can identify newly diagnosed patients with CLL at high risk of infection.
Nat Commun
; 11(1): 363, 2020 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953409
16.
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.
Leukemia
; 34(8): 2038-2050, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071431
17.
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Leukemia
; 34(4): 1038-1051, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042081
18.
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.
Nat Commun
; 9(1): 727, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463802
19.
Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.
Oncol Res Treat
; 39(1-2): 18-24, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891412